Geneexpression profiles of fatigued fibromyalgia patientswith different categories of pain andcatastrophizing: Apreliminary report

Nursing Outlook

Volumn 61, Issue 4, 2013, Pages

  Lukkahatai, Nada ^a   Majors, Benjamin ^a   Reddy, Swarnalatha ^a   Walitt, Brian ^b   Saligan, Leorey N ^a  

^a NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

Catastrophizing; Fatigue; Fibromyalgia; Gene expression; Microarray; Pain

Indexed keywords

ADULT; ARTICLE; CATASTROPHIZING; COMPARATIVE STUDY; DNA MICROARRAY; FATIGUE; FEMALE; FIBROMYALGIA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETICS; HUMAN; MICROARRAY; MIDDLE AGED; PAIN;

CATASTROPHIZING; FATIGUE; FIBROMYALGIA; GENE EXPRESSION; MICROARRAY; PAIN;

ADULT; CATASTROPHIZATION; FATIGUE; FEMALE; FIBROMYALGIA; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAIN;

EID: 84880153954     PISSN: 00296554     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.outlook.2013.03.007     Document Type: Article

References (55)

1. Aaron, L. A. (1999). The Moderating Effects of Catastrophizing as a Response to Daily Pain in Patients With Fibromyalgia (Unpublished doctoral dissertation). Birmingham, AL: University of Alabama at Birmingham.
2. Ablin J.N., Buskila D. The genetics of fibromyalgia-closing Osler's backdoor. Journal of the Israel Medical Association 2006, 8:428-429.
3. Ablin J.N., Cohen H., Buskila D. Mechanisms of disease: genetics of fibromyalgia. Nature Clinical Practice Rheumatology 2006, 2:671-678.
4. Ablin J.N., Shoenfeld Y., Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. Journal of Autoimmunity 2006, 27:145-152.
5. Anderson S., Skorpen F. Variation in the COMT gene: implications for pain perception and pain treatment. Phamacogenomics 2009, 10(4):669-684.
6. Arnold L.M., Crofford L.J., Mease P.J., Burgess S.M., Palmer S.C., Abetz L., Martin S.A. Patient perspectives on the impact of fibromyalgia. Patient Education and Counseling 2008, 73:114-120.
7. Bellato E., Marini E., Castoldi F., Barbasetti N., Mattei L., Bonasia D.E., Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis and treatment. Pain Research and Treatment 2012, 2012:426130.
8. Brita R., Xiao-Jun X., Jing-Xia H., Zsuzsanna W., Jama M., Gunnar G., Kristen K. Interferon receptors in nociceptive pathways: role in neuropathic pain-related behavior. Neuroreport 1997, 8:1311-1316.
9. Buenaver L.F., Edwards R.R., Haythornthwaite J.A. Pain-related catastrophizing and perceived social responses: inter-relationships in the context of chronic pain. Pain 2007, 127:234-242.
10. Buitenhuis J., De Jong P.J., Jaspers J.P.C., Groothoff J.W. Catastrophizing and causal beliefs in whiplash. Spine 2008, 33:2427-2433.
11. Burckhardt C.S., Clark S.R., Bennett R.M. Pain coping strategies and quality of life in women with fibromyalgia: does age make a difference?. Journal of Musculoskeletal Pain 2001, 9:5-18.
12. Burckhardt C.S., Clark S.R., O'Reilly C.A., Bennett R.M. Pain-Coping Strategies of women with fibromyalgia: relationship to pain, fatigue, and quality of life. Journal of Musculoskeletal Pain 1997, 5:5-21.
13. Burgmer M., Petzke F., Giesecke T., Gaubitz M., Heuft G., Pfleiderer B. Cerebral activation and catastrophizing during pain anticipation in patients with fibromyalgia. Psychosomatic Medicine 2011, 73:751-759.
14. Castel L.D., Abernethy A.P., Li Y., Depuy V., Saville B.R., Hartmann K.E. Hazards for pain severity and pain interference with daily living, with exploration of brief pain inventory cutpoints, among women with metastatic breast cancer. Journal of Pain and Symptom Management 2007, 34:380-392.
15. Clauw D.J. Fibromyalgia: an overview. American Journal of Medicine 2009, 122:S3-S13.
16. Cleeland C.S., Ladinsky J.L., Serlin R.C., Nugyen C.T. Multidimensional measurement of cancer pain: comparisons of US and Vietnamese patients. Journal of Pain and Symptom Management 1988, 3:23-27.
17. Desmeules J., Piguet V., Besson M., Chabert J., Rapiti E., Rabsamen M.,..., Cedraschi C. Psychological distress in fibromyalgia patients: a role of catechol-O-methyle-transferase Val158Met polymorphism. Health Psychology 2012, 31(2):242-249.
18. de Souza J.B., Goffaux P., Julien N., Potvin S., Charest J., Marchand S. Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatology International 2009, 29:509-515.
19. Edwards R.R., Cahalan C., Mensing G., Smith M., Haythornthwaite J.A. Pain, catastrophizing, and depression in the rheumatic diseases. Nature Reviews Rheumatology 2011, 7:216-224.
20. Finan P.H., Zautra A.J., Davis M.C., Lemery-Chalfant K., Covault J., Tennen H. COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain 2011, 152:300-307.
21. Finan P.H., Zautra A.J., Davis M.C., Lemery-Chalfant K., Covault J., Tennen H. Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychology 2010, 29:134-142.
22. George S.Z., Wallace M.R., Wright T.W., Moser M.W., Greenfield W.H., Sack B.K., ..., Fillingim R.B. Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain rating. Pain 2008, 136:53-61.
23. Giesecke T., Williams D.A., Harris R.E., Cupps T.R., Tian X., Tian T.X., ..., Clauw D.J. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis and Rheumatism 2003, 48:2916-2922.
24. Gow J.W., Hagan S., Herzyk P., Cannon C., Behan P.O., Chaudhuri A. Agene signature for post-infectious chronic fatigue syndrome. BMC Medical Genomics 2009, 2:38.
25. Gracely R.H., Geisser M.E., Giesecke T., Grant M.A., Petzke F., Williams D.A., Clauw D.J. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004, 127:835-843.
26. Gursoy S., Erdal E., Herken H., Madenci E., Alasehirli B., Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatology International 2003, 23(3):104-107.
27. Humphrey L., Arbuckle R., Mease P., Williams D.A., Samsoe B.D., Gilbert C. Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskeletal Disorders 2010, 11:216.
28. Jacobsen P.B., Andrykowski M.A., Thors C.L. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. Journal of Consulting and Clinical Psychology 2004, 72:355-361.
29. Jacobsen P.B., Azzarello L.M., Hann D.M. Relation of catastrophizing to fatigue severity in women with breast cancer. Cancer Research Therapy and Control 1999, 8:155-164.
30. Kapstad H., Rokne B., Stavem K. Psychometric properties of the Brief Pain Inventory among patients with osteoarthritis undergoing total hip replacement surgery. Health and Quality of Life Outcomes 2010, 8:148.
31. Lau A.C., Jongstra-Bilen J., Cybulsky M.I. Eicosapentaenoic acid and regression of atherosclerotic lesions: a role for dendritic cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1943-1945.
32. Light A.R., White A.T., Hughen R.W., Light K.C. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. JPain 2009, 10:1099-1112.
33. Low L.A., Schweinhardt P. Early life adversity as a risk factor for, fibromyalgia in ater life. Pain Research and Treatment 2012, 2012:140832.
34. Macedo J.A., Hesse J., Turner J.D., Meyer J., Hellhammer D.H., Muller C.P. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroidreceptor and glucocorticoid-induced leucinezipper. Psychoneuroendocrinology 2008, 33(6):799-809.
35. Maletic V., Raison C.L. Neurobiology of depression, fibromyalgia and neuropathic pain. Frontiers in Bioscience 2009, 14:5291-5338.
36. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. Journal of Rheumatology 2005, 75(6):21.
37. Osman A., Barrios F.X., Gutierrez P.M., Kopper B.A., Merrifield T., Grittmann L. The Pain Catastrophizing Scale: further psychometric evaluation with adult samples. Journal of Behavioral Medicine 2000, 23:351-365.
38. Osman A., Barrios F.X., Kopper B.A., Hauptmann W., Jones J., O'Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. Journal of Behavioral Medicine 1997, 20:589-605.
39. Reeves W.C., Wagner D., Nisenbaum R., Jones J.F., Gurbaxani B., Solomon L., ..., Heim C. Chronic fatigue syndrome-a clinically empirical approach to its definition and study. BMC Medicine 2005, 3:19.
40. Rehm S.E., Koroschetz J., Gockel U., Brosz M., Freynhagen R., Tolle T.R., Baron R. Across-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (Oxford) 2010, 49:1146-1152.
41. Riddle D.L., Wade J.B., Jiranek W.A., Kong X. Preoperative pain catastrophizing predicts pain outcome after knee arthroplasty. Clinical Orthopaedics and Related Research 2010, 468:798-806.
42. Sabban E.L. Catecholamines in stress: molecular mechanisms of gene expression. Endocrine Regulations 2007, 41:61-73.
43. Salemi S., Rathage J., Wollina U., Michel B.A., Gay R.E., Gay S., Sprott H. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. JRheumatol 2003, 30(1):146-150.
44. Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 1995, 39:315-325.
45. Sohl S.J., Friedberg F. Memory for fatigue in chronic fatigue syndrome: relationships to fatigue variability, catastrophizing, and negative affect. Behavioral Medicine 2008, 34:29-35.
46. Tsuda M., Masuda T., Kitano J., Shimoyama H., Tozaki-Saitoh H., Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proceedings of the National Academy of Sciences U S A 2009, 106:8032-8037.
47. Turk D.C., Okifuji A., Sinclair J.D., Starz T.W. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. The Journal of Rheumatology 1996, 23:1255-1262.
48. Turk D.C., Okifuji A., Sinclair J.D., Starz T.W. Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care & Research 1998, 11:397-404.
49. Wang X.M., Wu T.X., Hamza M., Ramsay E.S., Wahl S.M., Dionne R.A. Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 2007, 128:136-147.
50. White K.P., Speechley M., Harth M., Ostbye T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scandinavian Journal of Rheumatology 2000, 29:44-51.
51. Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Katz R.S., Mease P., ..., Yunus M.B. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research 2010, 62:600-610.
52. Wolfe F., Hawley D.J. Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clinical and Experimental Rheumatology 1999, 17:297-303.
53. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., ..., Sheon R.P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis & Rheumatism 1990, 33:160-172.
54. Wu Z., Irizarry R.A. Astatistical framework for the analysis of microarray probe-level data. The Annals of Applied Statistics 2007, 1(2):333-357.
55. Zhang J.M., Tonelli L., Regenold W.T., McCarthy M.M. Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats. Neuroscience 2010, 169:544-554.